Guess which ASX healthcare stock is rocketing 5% today (hint: not ResMed!)

This stock is outpacing the broader sector today.

| More on:
healthcare worker overseeing group of aged care residents at table

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX healthcare stocks are shining today and staging a recovery from the past week's sell-off.

At the time of writing, the S&P/ASX Healthcare Index (ASX: XHJ) is up more than 1% against the benchmark S&P/ASX 200 Index (ASX: XJO)'s 0.5% gain.

Regis Healthcare Ltd (ASX: REG) is an ASX healthcare stock that is on a roll today, surging 5% to fetch $4.36 per share at the time of writing.

Despite no market-sensitive announcements from the company, the stock is one of the top-performing healthcare names at the time of publication on Wednesday, according to CommSec data.

With many focused on health darlings like ResMed Inc (ASX: RMD), you don't want to miss the forest for the trees. There are plenty more names in the healthcare sector.

Let's dive into this lesser-known ASX healthcare stock.

ASX healthcare stock catching a bid

Regis Healthcare is one of Australia's largest aged care providers. The stock is up more than 78% in the past twelve months.

In May, Macquarie analysts rated the ASX healthcare stock a buy. According to my colleague James, the broker cited favourable recommendations from the Aged Care Taskforce as its reasoning.

These recommendations are aimed at supporting a sustainable and innovative aged care system, which bodes well for Regis' future growth, Macquarie says.

The anticipated increase in earnings through 2028 from the industry changes led Macquarie to lift its earnings estimates and set a price target of $5.50 on the ASX healthcare stock.

Financials also a talking point

Regis Healthcare's latest financial results are another talking point, in my opinion. For the first half of FY24, the company reported:

  • Revenue of $480.1 million, up 26% year on year
  • Pre-tax earnings of $52.1 million, a 16% increase compared to the previous period
  • Net profit of $16.3 million, up a staggering 527% from the same period last year

These underlying figures paint a positive picture of growth and profitability.

Whilst it operates in aged care, the ASX healthcare stock's management is rejuvenating the company's balance sheet.

For instance, the company's recent acquisition of CPSM has added five more aged care homes to its books.

This brings its total to 68 residences with 7,604 beds under management. In my view, this expansion has been a significant driver behind the ASX healthcare stock's gain over the past 12 months.

Foolish takeaway

Regis Healthcare is catching a strong bid on Wednesday despite no company-specific news.

With healthcare stocks in general staging a recovery today, it's not unlikely that investors saw an opportunity to buy a high-quality franchise with solid H1 FY24 financials.

It could also be speculation. Who's to truly know?

Past performance is no guarantee of future results, though. As always, conduct your own due diligence and consider chatting to a professional.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX healthcare share rockets 9% on upgraded profit growth guidance

This healthcare player has confirmed high growth for FY25.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Earnings Results

Telix share price sinks 9% despite stellar half-year growth

This radiopharmaceuticals company delivered strong growth during the first half.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Buy Pro Medicus and these ASX healthcare stocks now

These healthcare players are all primed according to top brokers.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

2 ASX healthcare shares outperforming peers on positive company news

Mesoblast has announced the resolution of a class action law suit against it today.

Read more »

digitised image of IVF taking place representing Virtus share price
Earnings Results

This high-performing ASX All Ords stock just crashed 12% on its earnings results. Here's why

Investors sent the ASX All Ords stock plunging following its full-year results. But why?

Read more »

Male doctor in a lab coat working at laptop looking serious.
Earnings Results

Medibank share price falls after FY24 result disappoints

How did the health insurer perform? Let's find out.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Earnings Results

Guess which ASX 200 healthcare stock just leapt 9% following its FY 2024 results

The ASX 200 healthcare stock is soaring following its full-year results. But why?

Read more »

Two people wearing gloves giving each other a fist bump.
Earnings Results

Ansell share price rockets higher on FY 2025 growth outlook

ASX 200 investors are sending the Ansell share price soaring on Tuesday. But why?

Read more »